Children With Diabetes and At Least One Non-Autoimmune Feature Should Be Considered for Monogenic Diabetes Testing - Quiz - MDSpire

Children With Diabetes and At Least One Non-Autoimmune Feature Should Be Considered for Monogenic Diabetes Testing

  • By

  • Rebecca Myers

  • Melek Yildiz

  • Mehmet Nuri Ozbek

  • Jaida Manzoor

  • Mohsina Ibrahim

  • Chittaranjan Yajnik

  • Muge Atar

  • Zeynep Şiklar

  • Sezer Acar

  • Evgenia Globa

  • Omneya Magdy Omar

  • Huseyin Demirbilek

  • Samar Hassan

  • Korcan Demir

  • Misbah Hanif

  • Tulay Guran

  • Nihal Hatipoglu

  • Cemil Koçyiğit

  • Kevin Colclough

  • Jayne Houghton

  • Andrew Hattersley

  • Rachel Van Heugten

  • Kashyap Patel

  • Monogenic Diabetes Consortium

  • Y Abdelmeguid

  • S Abourazzak

  • A Annamalai

  • E Bhowmik

  • G Catli

  • S Chapman

  • H Eideh

  • V Jain

  • T Kontbay

  • V Mulliqi Kotori

  • G Supriya

  • S Musa

  • M Šandrk Beslać

  • M Sharaf

  • J Yong

  • G Yesiltepe Mutlu

  • R Yildirim

  • O Yilmaz

  • M Berberoglu

  • T Akcay

  • C Datar

  • S Dhadge

  • K Jog

  • August 1, 2025

  • 0 min

Share

Original Source(s)

Children With Diabetes and At Least One Non-Autoimmune Feature Should Be Considered for Monogenic Diabetes Testing

  • by Rebecca Myers, Melek Yildiz, Mehmet Nuri Ozbek, Jaida Manzoor, Mohsina Ibrahim, Chittaranjan Yajnik, Muge Atar, Zeynep Şiklar, Sezer Acar, Evgenia Globa, Omneya Magdy Omar, Huseyin Demirbilek, Samar Hassan, Korcan Demir, Misbah Hanif, Tulay Guran, Nihal Hatipoglu, Cemil Koçyiğit, Kevin Colclough, Jayne Houghton, Andrew Hattersley, Rachel Van Heugten, Kashyap Patel, Monogenic Diabetes Consortium, Y Abdelmeguid, S Abourazzak, A Annamalai, E Bhowmik, G Catli, S Chapman, H Eideh, V Jain, T Kontbay, V Mulliqi Kotori, G Supriya, S Musa, M Šandrk Beslać, M Sharaf, J Yong, G Yesiltepe Mutlu, R Yildirim, O Yilmaz, M Berberoglu, T Akcay, C Datar, S Dhadge, K Jog

  • August 1, 2025

Related Content

Diabetes Risk Scores: Beyond Glucose

Multi-ancestry polygenic models identify high-risk patients traditional screening may miss.

Semaglutide Linked to NAION Risk

A retrospective database study found a low absolute incidence but higher relative hazard of ischemic optic neuropathy following semaglutide initiation.

Increasing incidence and severity of childhood-onset type 1 diabetes in Latvia during the COVID-19 pandemic